ciprofloxacin has been researched along with sarafloxacin in 98 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (29.59) | 18.7374 |
| 1990's | 15 (15.31) | 18.2507 |
| 2000's | 29 (29.59) | 29.6817 |
| 2010's | 22 (22.45) | 24.3611 |
| 2020's | 3 (3.06) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzard, D; Di Cesare, P; Essiz, M; Jacquet, JP; Masuyoshi, M; Oki, T; Remuzon, P; Weber, A | 1 |
| Dever, JA; Domagala, JM; Gracheck, SJ; Renau, TE; Sanchez, JP; Shapiro, MA | 1 |
| Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Chen, L; Fan, L; He, ZQ; Jiang, L; Lei, HS; Liu, CP; Liu, J; Peng, XM; Xu, XR; Yang, DC; Zhou, CH; Zhou, FW; Zou, YY | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| Pattyn, SR | 1 |
| Amyes, SG; Barnes, AC; Hastings, TS; Lewin, CS | 1 |
| Bauer, JF; Elrod, L; Fornnarino, JR; Heathcote, DE; Krogh, SK; Linton, CL; Norris, BJ; Quick, JE | 1 |
| Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C | 1 |
| Chandrasekar, PH; Sluchak, JA | 1 |
| Ayers, LW; Barry, AL; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Smith, SM | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
| Liu, S; Meyer, RD | 1 |
| Fok, M; Gollapudi, SV; Gupta, S; Thadepalli, H; Vayuvegula, B | 1 |
| Michel, MF; Piot, P; Stolz, E; Tjiam, KH; van Klingeren, B; Wagenvoort, JH | 1 |
| Black, WA; Bowie, WR; Boyd, J; Chan, DG; Shaw, CE | 1 |
| Ballard, RC; Fehler, G; Koornhof, HJ; Liebowitz, LD; Saunders, J | 1 |
| Berlin, OG; Bruckner, DA; Young, LS | 1 |
| Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
| Verbist, L | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, K | 1 |
| Dibb, WL; Digranes, A | 1 |
| Deforges, L; Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Ackerman, VP; Fernandes, CJ; Wilson, RD | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 2 |
| King, A; Phillips, I | 1 |
| Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N | 1 |
| Chuah, SK; Gollapudi, SV; Thadepalli, H | 1 |
| Adams, KR; Mader, JT; Morrison, LT | 1 |
| Bansal, MB; Thadepalli, H | 1 |
| Donato, JB; Joseph, WS; LeFrock, JL; Smith, BR; Weber, SJ | 1 |
| Hirschhorn, L; Neu, HC | 1 |
| Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E | 1 |
| Eliopoulos, GM; Moellering, AE; Moellering, RC; Reiszner, E | 1 |
| Dijkstra, JW; McConville, ML; Nouws, JF; Stamm, JM; van Saene, JJ | 1 |
| Horsberg, TE; Martinsen, B | 1 |
| Courvalin, P; Duval, J; Tankovic, J | 1 |
| Giles, JS; Hariharan, H; Heaney, SB | 1 |
| Erwin, ME; Jones, RN | 1 |
| Cohen, E; Donoghue, DJ; Maxwell, RJ | 2 |
| Cheng, CF; Ho, SP; Wang, WS | 1 |
| Ellis, R; Niedzielska, J; Posyniak, A; Semeniuk, S; Zmudzki, J | 1 |
| Bauer, JF; Dziki, W; Nichols, BC; Quick, JE; Szpylman, JJ | 1 |
| Chang, HC; Li, LC; Plichta-Mahmoud, H; Stephens, D; Toongsuwan, S | 1 |
| Holtzapple, CK; Pishko, EJ; Stanker, LH | 1 |
| Chu, PS; Donoghue, DJ; Shaikh, B | 1 |
| Buckley, SA; Holtzapple, CK; Stanker, LH | 1 |
| Beger, RD; Freeman, JP; Lay, JO; Moody, JD; Parshikov, IA; Sutherland, JB; Williams, AJ | 1 |
| Chen, ZL; Ding, HZ; Fung, KF; Qiao, GL; Zeng, ZL | 1 |
| Chang, HC; Li, LC; Liu, RM; Plichta-Mahmoud, H; Stephens, D; Toongsuwan, S | 1 |
| Bailac, S; Barbosa, J; Barrón, D; Jiménez-Lozano, E | 1 |
| Chu, HV; Chu, PS; Wang, RC | 1 |
| Chansiripornchai, N; Sasipreeyajan, J | 1 |
| Roudaut, B; Yorke, JC | 1 |
| Chang, J; Guo, R; He, J; Kuang, A; Lin, S; Liu, P | 1 |
| Chang, HC; Li, LC; Robinson, D; Stephens, D; Toongsuwan, S | 1 |
| Hatano, K | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Bermejo, M; Casabó, VG; Fernandez-Teruel, C; Gonzalez-Alvarez, I; Ruiz-Garcia, A | 1 |
| Dong, L; Gao, L; Liu, Y; Peng, L; Wang, X; Yue, X; Zhong, F | 1 |
| Herranz, S; Marazuela, MD; Moreno-Bondi, MC | 1 |
| Darwish, AM; Freeman, DW; Schneider, MJ | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Arner, A; Boels, PJ; Oldner, A; Persson, B; Rossi, P; Weitzberg, E | 1 |
| Marazuela, MD; Moreno-Bondi, MC; Rodriguez, E | 1 |
| Kusari, S; Lamshöft, M; Spiteller, M; Sukul, P; Zühlke, S | 1 |
| Kusari, S; Lamshöft, M; Prabhakaran, D; Spiteller, M | 1 |
| Paschoal, JA; Rath, S; Reyes, FG | 1 |
| Bohoyo Gil, D; Guiberteau Cabanillas, A; Martínez Cañas, MA; Rodríguez Cáceres, MI | 1 |
| Lamshöft, M; Maheswari, MA; Prabhakaran, D; Spiteller, M; Sukul, P; Zühlke, S | 1 |
| Galeano Díaz, T; Guiberteau Cabanillas, A; Martínez Cañas, MA; Rodríguez Cáceres, MI | 1 |
| Guo, K; Ji, H; Jiang, SX; Zhang, JR; Zhang, LL; Zhang, Y | 1 |
| Abd El-Aty, AM; Choi, JH; Mamun, MI; Na, TW; Park, JH; Shim, JH; Shin, EH | 1 |
| Anadón, A; Ares, I; Castellano, V; Gamboa, F; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Ramos, E; Suárez, FH | 1 |
| Karisa, J; Kokwaro, GO; Maitland, K; Muchohi, SN; Muturi, A; Thuo, N | 1 |
| Cruces-Blanco, C; Gámiz-Gracia, L; García-Campaña, AM; Lombardo-Agüí, M | 1 |
| Boitiaux, JF; Cazes, A; Delclaux, C; Devillier, P; Douvry, B; Henno, P; Israël-Biet, D; Lévy, M | 1 |
| Liu, J; Liu, YZ; Wang, JP; Wang, P; Zhang, HC; Zhao, GX | 1 |
| Cao, Z; Liu, R; Yang, B | 1 |
| Orlando, RM; Rath, S; Rohwedder, JJ | 1 |
| Companyó, R; Guiteras, J; Jiménez, V | 1 |
| Cao, Z; Chen, Y; Dong, Z; Liu, R; Yang, X | 1 |
| Kang, H; Lin, L; Luo, Y; Tu, X; Wu, W; Xie, L; Yue, Z; Zhang, Y | 1 |
| Fang, X; Liu, X; Zhou, J | 1 |
| Cui, M; Duan, S; Li, T; Liu, B | 1 |
| Albiol-Chiva, J; Carda-Broch, S; Esteve-Romero, J; Iborra-Millet, JJ; Peris-Vicente, J | 1 |
| Amou, E; Asadipour, A; Beiki, K; Firoozpour, L; Foroumadi, A; Ilbeigi, G; Khosravani, L; Moghimi, S; Moshafi, MH; Soleimani, E | 1 |
| Chen, Y; Fang, B; Hu, S; Huang, Z; Lai, W; Liu, D; Peng, J; Xing, K | 1 |
| Bunkoed, O; Chaowana, R | 1 |
| Bijanzadeh, HR; Emamgholipour, Z; Foroumadi, A; Güran, M; Norouzbahari, M; Salarinejad, S; Şanlıtürk, G; Toolabi, M | 1 |
| Al-Meer, S; Al-Saad, KA; El-Azazy, M; El-Shafie, AS; Elgendy, A; Issa, AA | 1 |
| Cai, T; Gong, B; Li, J; Liu, H; Wang, X; Zhao, S; Zhou, Y | 1 |
1 review(s) available for ciprofloxacin and sarafloxacin
| Article | Year |
|---|---|
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
1 trial(s) available for ciprofloxacin and sarafloxacin
| Article | Year |
|---|---|
Efficacy of sarafloxacin in broilers after experimental infection with Escherichia coli.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli Infections; Female; Fluoroquinolones; Male; Poultry Diseases | 2002 |
96 other study(ies) available for ciprofloxacin and sarafloxacin
| Article | Year |
|---|---|
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Dogs; Gram-Negative Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Staphylococcus; Structure-Activity Relationship | 1989 |
Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Mycobacterium; Piperazines; Structure-Activity Relationship | 1995 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents.
Topics: Antitubercular Agents; Artemisinins; Drug Design; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2014 |
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobacterium leprae; Quinolones | 1991 |
In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.
Topics: Aeromonas; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Osmolar Concentration; Oxolinic Acid; Quinolones; Sodium Chloride | 1990 |
Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Quinolones; Solubility; Spectrophotometry, Ultraviolet | 1990 |
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1990 |
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Species Specificity; Staphylococcus aureus | 1989 |
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolines; Staphylococcus; Streptococcus | 1986 |
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa | 1986 |
Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Mitogens; Monocytes; Receptors, Immunologic; Receptors, Interleukin-2 | 1986 |
In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Topics: Anti-Bacterial Agents; Bacteria; Chlamydia trachomatis; Ciprofloxacin; Fluoroquinolones; Gardnerella vaginalis; Humans; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Tetracycline; Ureaplasma | 1986 |
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1986 |
In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Haemophilus; Haemophilus ducreyi; Humans; Male; Microbial Sensitivity Tests; Mycoplasma; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Oxazines; Ureaplasma | 1986 |
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines | 1987 |
In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1988 |
In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 1988 |
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pseudomonas; Staphylococcus; Streptococcus | 1988 |
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patients.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms; Quinones; Sepsis | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines | 1987 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections | 1986 |
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Half-Life; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains | 1986 |
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Ciprofloxacin; Fluoroquinolones; Nafcillin; Osteomyelitis; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution | 1987 |
Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Cefoxitin; Ciprofloxacin; Drug Synergism; Fluoroquinolones; Microbial Sensitivity Tests; Species Specificity | 1987 |
In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolines | 1986 |
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Magnesium; Piperazines; Quinolines | 1986 |
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1985 |
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Piperazines; Pseudomonas aeruginosa; Quinolines; Time Factors | 1985 |
Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Bifidobacterium; Ciprofloxacin; Colony Count, Microbial; Digestive System; Drug Evaluation, Preclinical; Drug Residues; Escherichia coli; Fluoroquinolones; Humans; Intestinal Mucosa; Microbial Sensitivity Tests; Models, Biological | 1995 |
Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 degrees C.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Injections, Intravenous; Oxolinic Acid; Quinolizines; Quinolones; Salmon; Seawater; Temperature | 1995 |
Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Probes; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Molecular Sequence Data; Mutation; Plasmids; Staphylococcus aureus | 1994 |
A microbiological assay for determining sarafloxacin and oxolinic acid concentrations in Atlantic salmon plasma.
Topics: Animals; Anti-Infective Agents; Bacillus subtilis; Biological Assay; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Oxolinic Acid; Salmon; Vibrio | 1994 |
In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Infection Control; Microbial Sensitivity Tests; Poultry Diseases; Quality Control | 1998 |
Automated multi-residue isolation of fluoroquinolone antimicrobials from fortified and incurred chicken liver using on-line microdialysis and high-performance liquid chromatography with programmable fluorescence detection.
Topics: Animals; Anti-Infective Agents; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Liver; Oxolinic Acid; Quinolizines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 1999 |
Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla).
Topics: Administration, Oral; Anguilla; Animals; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Half-Life; Kidney; Liver; Metabolic Clearance Rate; Muscle, Skeletal; Skin; Tissue Distribution | 1999 |
Determination of fluoroquinolone residues in animal tissues by liquid chromatography.
Topics: Animals; Anti-Infective Agents; Cattle; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Kidney; Liver; Muscles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Swine | 1999 |
Determination of sarafloxacin residues in fortified and incurred eggs using on-line microdialysis and HPLC/programmable fluorescence detection.
Topics: Animals; Anti-Infective Agents; Automation; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Eggs; Female; Fluoroquinolones; Microdialysis; Oviposition | 1999 |
The use of near-infrared spectroscopy to monitor the mobility of water within the sarafloxacin crystal lattice.
Topics: Anti-Infective Agents; Calorimetry, Differential Scanning; Ciprofloxacin; Crystallography, X-Ray; Fluoroquinolones; Spectroscopy, Near-Infrared; Water | 2000 |
Particle size determination of a three-component suspension using a laser-scattering particle size distribution analyzer.
Topics: Anti-Infective Agents; Ciprofloxacin; Clotrimazole; Fluoroquinolones; Lasers; Particle Size; Refractometry; Suspensions; Triamcinolone | 2000 |
Separation and quantification of two fluoroquinolones in serum by on-line high-performance immunoaffinity chromatography.
Topics: Anti-Infective Agents; Chromatography, Affinity; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Immunoassay; Quinolones | 2000 |
FDA hastening withdrawal of fluoroquinolone approvals for poultry.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Drug Approval; Enrofloxacin; Fluoroquinolones; Quinolones; Risk Assessment; Turkeys; United States; United States Food and Drug Administration | 2000 |
Determination of total 14C residues of sarafloxacin in eggs of laying hens.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Carbon Isotopes; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Egg Proteins; Egg Yolk; Female; Fluoroquinolones | 2000 |
Determination of fluoroquinolones in serum using an on-line clean-up column coupled to high-performance immunoaffinity-reversed-phase liquid chromatography.
Topics: Animals; Anti-Infective Agents; Cattle; Chromatography, Affinity; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Immunochemistry; Molecular Structure; Quinolones | 2001 |
Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus.
Topics: Animals; Anti-Infective Agents; Biodegradation, Environmental; Ciprofloxacin; Fluoroquinolones; Mucor; Soil Pollutants; Veterinary Medicine | 2001 |
Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Male; Metabolic Clearance Rate; Species Specificity; Swine; Tissue Distribution | 2001 |
Development of a topical suspension containing three active ingredients.
Topics: Administration, Topical; Anti-Infective Agents; Buffers; Ciprofloxacin; Clotrimazole; Drug Combinations; Drug Compounding; Drug Stability; Excipients; Fluoroquinolones; Solutions; Suspensions; Temperature; Time Factors; Triamcinolone Acetonide | 2002 |
Determination of difloxacin and sarafloxacin in chicken muscle using solid-phase extraction and capillary electrophoresis.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Drug Residues; Electrophoresis, Capillary; Fluoroquinolones; Muscles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Liquid chromatographic determination of fluoroquinolones in egg albumen and egg yolk of laying hens using fluorometric detection.
Topics: Animals; Anti-Infective Agents; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Egg Yolk; Enrofloxacin; Female; Fluorometry; Fluoroquinolones; Ovalbumin; Poultry Diseases; Quality Control; Quinolones; Veterinary Drugs | 2002 |
High-performance liquid chromatographic method with fluorescence detection for the screening and quantification of oxolinic acid, flumequine and sarafloxacin in fish.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Fishes; Fluoroquinolones; Oxolinic Acid; Quinolizines; Reproducibility of Results; Spectrometry, Fluorescence | 2002 |
[Determination of sarafloxacin by high performance liquid chromatography (HPLC)].
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones | 1999 |
Heat-induced formulation inhomogeneity of a three-component suspension.
Topics: Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ciprofloxacin; Clotrimazole; Dogs; Drug Stability; Drug Storage; Fluoroquinolones; Glucocorticoids; Hot Temperature; Otitis Externa; Suspensions; Triamcinolone Acetonide | 2004 |
[Simultaneous determination of quinolones in foods by LC/MS/MS].
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fishes; Fluoroquinolones; Food Analysis; Meat; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization | 2004 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.
Topics: Adenosine Triphosphate; Algorithms; Animals; Anti-Infective Agents; Antimetabolites; Biological Transport; Caco-2 Cells; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Diffusion; Energy Metabolism; Fluoroquinolones; Humans; Intestinal Absorption; Intestinal Mucosa; Lipids; Male; Models, Statistical; Oxidative Phosphorylation; Rats; Rats, Wistar; Sodium Azide | 2005 |
[Simultaneous determination of four fluoroquinolone residues in edible chicken tissues by reversed-phase high performance liquid chromatography].
Topics: Animals; Anti-Infective Agents; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Enrofloxacin; Fluoroquinolones; Muscles; Pesticide Residues | 2005 |
Development of a new sample pretreatment procedure based on pressurized liquid extraction for the determination of fluoroquinolone residues in table eggs.
Topics: Animals; Chemical Fractionation; Chickens; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Eggs; Enrofloxacin; Female; Fluorescence; Fluoroquinolones; Mass Spectrometry; Pressure; Temperature | 2007 |
Simultaneous multiresidue determination of tetracyclines and fluoroquinolones in catfish muscle using high performance liquid chromatography with fluorescence detection.
Topics: Animals; Catfishes; Chlortetracycline; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Enrofloxacin; Fluoroquinolones; Muscles; Oxytetracycline; Spectrometry, Fluorescence; Tetracyclines | 2007 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.
Topics: Animals; Ciprofloxacin; Endothelin-1; Female; Hypertension, Pulmonary; Lipopolysaccharides; Lung; Male; Pyridines; Respiratory Distress Syndrome; Sepsis; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2008 |
Development and validation of a solid-phase extraction method coupled to liquid chromatography with fluorescence detection for the determination of fluoroquinolone residues in powdered infant formulae. Application to the analysis of samples from the Spani
Topics: Chromatography, Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Humans; Infant; Infant Formula; Latin America; Molecular Structure; Reproducibility of Results; Solid Phase Extraction; Spain; Spectrometry, Fluorescence | 2008 |
Metabolism and excretion kinetics of 14C-labeled and non-labeled difloxacin in pigs after oral administration, and antimicrobial activity of manure containing difloxacin and its metabolites.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Calibration; Carbon Radioisotopes; Ciprofloxacin; Environmental Pollutants; Male; Manure; Microbial Sensitivity Tests; Reference Standards; Swine | 2009 |
In vitro residual anti-bacterial activity of difloxacin, sarafloxacin and their photoproducts after photolysis in water.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Residues; Photolysis; Water Pollutants, Chemical | 2009 |
Quantitation and identity confirmation of residues of quinolones in tilapia fillets by LC-ESI-MS-MS QToF.
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Food Analysis; Oxolinic Acid; Quinolones; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tilapia | 2009 |
Quantification of danofloxacin and difloxacin in chicken tissues in the presence of sarafloxacin as interference.
Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Fluoroquinolones; Food Contamination; Muscles; Reproducibility of Results; Spectrometry, Fluorescence | 2009 |
Photolysis of difloxacin and sarafloxacin in aqueous systems.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Environmental Restoration and Remediation; Half-Life; Humic Substances; Hydrogen-Ion Concentration; Kinetics; Light; Photolysis; Water; Water Pollutants, Chemical | 2009 |
Simultaneous determination of quinolones for veterinary use by high-performance liquid chromatography with electrochemical detection.
Topics: Animals; Calibration; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Electrochemical Techniques; Electrodes; Fluoroquinolones; Reference Standards; Regression Analysis; Rheology; Veterinary Drugs | 2010 |
Effects of fluoroquinolones on CYP4501A and 3A in male broilers.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Caffeine; Chickens; Ciprofloxacin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Drug Interactions; Enrofloxacin; Fluoroquinolones; Gene Expression Regulation, Enzymologic; Half-Life; Liver; Male; Organ Size; Weight Gain | 2011 |
Bufferized solvent extraction and HPLC fluorometric detection method for sarafloxacin in pig and chicken muscles.
Topics: Acetonitriles; Animals; Buffers; Chemical Fractionation; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Fluorometry; Food Analysis; Hexanes; Meat; Muscles; Reproducibility of Results; Sensitivity and Specificity; Swine | 2011 |
Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Chickens; Ciprofloxacin; Drug Residues; Drug Resistance; Half-Life; Injections, Intravenous; Microbial Sensitivity Tests; Molecular Structure | 2011 |
Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition.
Topics: Child; Child Nutrition Disorders; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Humans; Least-Squares Analysis; Malnutrition; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2011 |
Comparison of different sample treatments for the analysis of quinolones in milk by capillary-liquid chromatography with laser induced fluorescence detection.
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Lasers; Linear Models; Milk; Molecular Imprinting; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2011 |
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Oligopeptides; Peptides, Cyclic; Piperidines; Pulmonary Circulation; Receptor, Endothelin A; Receptor, Endothelin B; Smoking; Vascular Diseases; Vasodilation; Vasodilator Agents | 2011 |
Production of the broad specific monoclonal antibody against sarafloxacin for rapid immunoscreening of 12 fluoroquinolones in meat.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Chickens; Ciprofloxacin; Cross Reactions; Drug Residues; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Food Contamination; Haptens; Meat; Muscle, Skeletal | 2013 |
Potential toxicity of sarafloxacin to catalase: spectroscopic, ITC and molecular docking descriptions.
Topics: Animals; Binding Sites; Calorimetry; Catalase; Cattle; Ciprofloxacin; Circular Dichroism; Molecular Docking Simulation; Protein Binding; Protein Structure, Secondary; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics; Time Factors; Titrimetry | 2013 |
Semiautomated solid-phase extraction manifold with a solvent-level sensor.
Topics: Animals; Anti-Bacterial Agents; Automation, Laboratory; Calibration; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Milk; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Solvents | 2013 |
Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Oxolinic Acid; Quality Control; Quinolones; Reproducibility of Results | 2012 |
The effect of sarafloxacin on Cu/ZnSOD structure and activity.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Enzyme Activation; Molecular Docking Simulation; Protein Binding; Protein Conformation; Superoxide Dismutase; Swine | 2015 |
[Determination of 25 quinolones in cosmetics by liquid chromatography-tandem mass spectrometry].
Topics: Chromatography, Liquid; Ciprofloxacin; Cosmetics; Drug Residues; Enrofloxacin; Fluoroquinolones; Hexanes; Norfloxacin; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Pharmacokinetics of sarafloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Carps; Ciprofloxacin; Models, Biological | 2016 |
Fluorescence spectra, fluorescence quantum yield and dissociation constant of sarafloxacin.
Topics: Ciprofloxacin; Fluorescence; Hydrogen-Ion Concentration; Protons; Spectrometry, Fluorescence | 2017 |
A rapid and reliable assay to determine flumequine, marbofloxacin, difloxacin, and sarafloxacin in commonly consumed meat by micellar liquid chromatography.
Topics: Animals; Anti-Bacterial Agents; Cattle; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Food Contamination; Goats; Horses; Meat; Poultry; Rabbits; Sheep; Swine | 2019 |
N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Ciprofloxacin; Drug Design; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2018 |
Using molecular descriptors for assisted screening of heterologous competitive antigens to improve the sensitivity of ELISA for detection of enrofloxacin in raw milk.
Topics: Animals; Anti-Bacterial Agents; Antigens, Heterophile; Cattle; Ciprofloxacin; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Milk; Serum Albumin, Bovine | 2019 |
A nanocomposite probe of polydopamine/molecularly imprinted polymer/quantum dots for trace sarafloxacin detection in chicken meat.
Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Fluorescent Dyes; Food Contamination; Indoles; Limit of Detection; Meat; Molecular Imprinting; Polymers; Poultry; Quantum Dots | 2019 |
Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Quinazolinones; Structure-Activity Relationship | 2020 |
A Comparison between Different Agro-Wastes and Carbon Nanotubes for Removal of Sarafloxacin from Wastewater: Kinetics and Equilibrium Studies.
Topics: Adsorption; Agriculture; Analysis of Variance; Ciprofloxacin; Hydrogen-Ion Concentration; Kinetics; Nanotubes, Carbon; Pistacia; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermogravimetry; Wastewater; Water Pollutants, Chemical | 2020 |
Preparation of monodisperse, restricted-access, media-molecularly imprinted polymers using bi-functional monomers for solid-phase extraction of sarafloxacin from complex samples.
Topics: Adsorption; Ciprofloxacin; Cross-Linking Reagents; Kinetics; Methacrylates; Microspheres; Molecular Imprinting; Molecularly Imprinted Polymers; Polymerization; Solid Phase Extraction | 2021 |